Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 59

1.

Development and Validation of a Pragmatic Electronic Phenotype for CKD.

Norton JM, Ali K, Jurkovitz CT, Kiryluk K, Park M, Kawamoto K, Shang N, Navaneethan SD, Narva AS, Drawz P.

Clin J Am Soc Nephrol. 2019 Aug 12. pii: CJN.00360119. doi: 10.2215/CJN.00360119. [Epub ahead of print]

PMID:
31405830
2.

Effect of Intensive and Standard Clinic-Based Hypertension Management on the Concordance Between Clinic and Ambulatory Blood Pressure and Blood Pressure Variability in SPRINT.

Ghazi L, Pajewski NM, Rifkin DE, Bates JT, Chang TI, Cushman WC, Glasser SP, Haley WE, Johnson KC, Kostis WJ, Papademetriou V, Rahman M, Simmons DL, Taylor A, Whelton PK, Wright JT, Bhatt UY, Drawz PE.

J Am Heart Assoc. 2019 Jul 16;8(14):e011706. doi: 10.1161/JAHA.118.011706. Epub 2019 Jul 15.

3.

Trends in Angiotensin-Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use among Those with Impaired Kidney Function in the United States.

Murphy DP, Drawz PE, Foley RN.

J Am Soc Nephrol. 2019 Jul;30(7):1314-1321. doi: 10.1681/ASN.2018100971. Epub 2019 Jun 5.

PMID:
31167823
4.

Masked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events.

Babu M, Drawz P.

Curr Cardiol Rep. 2019 May 20;21(7):58. doi: 10.1007/s11886-019-1154-4. Review.

PMID:
31111326
5.

Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease.

Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH; for the SPRINT Research Group.

Am J Nephrol. 2019;49(5):346-355. doi: 10.1159/000499531. Epub 2019 Apr 2.

PMID:
30939472
6.

Blood Pressure Assessment in Adults in Clinical Practice and Clinic-Based Research: JACC Scientific Expert Panel.

Muntner P, Einhorn PT, Cushman WC, Whelton PK, Bello NA, Drawz PE, Green BB, Jones DW, Juraschek SP, Margolis KL, Miller ER 3rd, Navar AM, Ostchega Y, Rakotz MK, Rosner B, Schwartz JE, Shimbo D, Stergiou GS, Townsend RR, Williamson JD, Wright JT Jr, Appel LJ; 2017 National Heart, Lung, and Blood Institute Working Group.

J Am Coll Cardiol. 2019 Jan 29;73(3):317-335. doi: 10.1016/j.jacc.2018.10.069. Review.

PMID:
30678763
7.

Blood Pressure Variability in CKD: Treatable or Hypertension's Homocysteine?

Murphy D, Drawz PE.

Clin J Am Soc Nephrol. 2019 Jan 18. pii: CJN.14991218. doi: 10.2215/CJN.14991218. [Epub ahead of print] No abstract available.

PMID:
30659058
8.

Kidney Damage Biomarkers and Incident Chronic Kidney Disease During Blood Pressure Reduction: A Case-Control Study.

Zhang WR, Craven TE, Malhotra R, Cheung AK, Chonchol M, Drawz P, Sarnak MJ, Parikh CR, Shlipak MG, Ix JH; SPRINT Research Group.

Ann Intern Med. 2018 Nov 6;169(9):610-618. doi: 10.7326/M18-1037. Epub 2018 Oct 23.

PMID:
30357395
9.

Masked Uncontrolled Hypertension.

Drawz PE.

Hypertension. 2018 Oct;72(4):843-845. doi: 10.1161/HYPERTENSIONAHA.118.11640. No abstract available.

PMID:
30354733
10.

Pulse wave velocity and central aortic pressure in systolic blood pressure intervention trial participants.

Supiano MA, Lovato L, Ambrosius WT, Bates J, Beddhu S, Drawz P, Dwyer JP, Hamburg NM, Kitzman D, Lash J, Lustigova E, Miracle CM, Oparil S, Raj DS, Weiner DE, Taylor A, Vita JA, Yunis R, Chertow GM, Chonchol M.

PLoS One. 2018 Sep 26;13(9):e0203305. doi: 10.1371/journal.pone.0203305. eCollection 2018.

11.

Race, Ethnicity, and End-of-Life Care in Dialysis Patients in the United States.

Foley RN, Sexton DJ, Drawz P, Ishani A, Reule S.

J Am Soc Nephrol. 2018 Sep;29(9):2387-2399. doi: 10.1681/ASN.2017121297. Epub 2018 Aug 9.

PMID:
30093455
12.

Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.

Drawz PE, Brown R, De Nicola L, Fujii N, Gabbai FB, Gassman J, He J, Iimuro S, Lash J, Minutolo R, Phillips RA, Rudser K, Ruilope L, Steigerwalt S, Townsend RR, Xie D, Rahman M; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2018 Sep 7;13(9):1348-1357. doi: 10.2215/CJN.13181117. Epub 2018 Jul 5.

PMID:
29976600
13.

The impact of outpatient acute kidney injury on mortality and chronic kidney disease: a retrospective cohort study.

Leither MD, Murphy DP, Bicknese L, Reule S, Vock DM, Ishani A, Foley RN, Drawz PE.

Nephrol Dial Transplant. 2019 Mar 1;34(3):493-501. doi: 10.1093/ndt/gfy036.

14.

BP Measurement Techniques: What They Mean for Patients with Kidney Disease.

Thomas G, Drawz PE.

Clin J Am Soc Nephrol. 2018 Jul 6;13(7):1124-1131. doi: 10.2215/CJN.12551117. Epub 2018 Feb 26. Review.

15.

Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease.

Rahman M, Hsu JY, Desai N, Hsu CY, Anderson AH, Appel LJ, Chen J, Cohen DL, Drawz PE, He J, Qiang P, Ricardo AC, Steigerwalt S, Weir MR, Wright JT Jr, Zhang X, Townsend RR; CRIC Study Investigators.

Clin J Am Soc Nephrol. 2018 Apr 6;13(4):585-595. doi: 10.2215/CJN.08620817. Epub 2018 Feb 23.

17.

Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).

Rocco MV, Sink KM, Lovato LC, Wolfgram DF, Wiegmann TB, Wall BM, Umanath K, Rahbari-Oskoui F, Porter AC, Pisoni R, Lewis CE, Lewis JB, Lash JP, Katz LA, Hawfield AT, Haley WE, Freedman BI, Dwyer JP, Drawz PE, Dobre M, Cheung AK, Campbell RC, Bhatt U, Beddhu S, Kimmel PL, Reboussin DM, Chertow GM; SPRINT Research Group.

Am J Kidney Dis. 2018 Mar;71(3):352-361. doi: 10.1053/j.ajkd.2017.08.021. Epub 2017 Nov 20.

18.

BP Measurement in Clinical Practice: Time to SPRINT to Guideline-Recommended Protocols.

Drawz PE, Ix JH.

J Am Soc Nephrol. 2018 Feb;29(2):383-388. doi: 10.1681/ASN.2017070753. Epub 2017 Oct 19. Review.

19.

Blood pressure and the risk of chronic kidney disease progression using multistate marginal structural models in the CRIC Study.

Stephens-Shields AJ, Spieker AJ, Anderson A, Drawz P, Fischer M, Sozio SM, Feldman H, Joffe M, Yang W, Greene T; CRIC Study Investigators.

Stat Med. 2017 Nov 20;36(26):4167-4181. doi: 10.1002/sim.7425. Epub 2017 Aug 9.

20.

Clinical Implications of Different Blood Pressure Measurement Techniques.

Drawz P.

Curr Hypertens Rep. 2017 Jul;19(7):54. doi: 10.1007/s11906-017-0751-0. Review.

PMID:
28551831
21.

Advances in understanding the renin-angiotensin-aldosterone system (RAAS) in blood pressure control and recent pivotal trials of RAAS blockade in heart failure and diabetic nephropathy.

Ghazi L, Drawz P.

F1000Res. 2017 Mar 21;6. pii: F1000 Faculty Rev-297. doi: 10.12688/f1000research.9692.1. eCollection 2017. Review.

22.

Effect of Intensive Versus Standard Clinic-Based Hypertension Management on Ambulatory Blood Pressure: Results From the SPRINT (Systolic Blood Pressure Intervention Trial) Ambulatory Blood Pressure Study.

Drawz PE, Pajewski NM, Bates JT, Bello NA, Cushman WC, Dwyer JP, Fine LJ, Goff DC Jr, Haley WE, Krousel-Wood M, McWilliams A, Rifkin DE, Slinin Y, Taylor A, Townsend R, Wall B, Wright JT, Rahman M.

Hypertension. 2017 Jan;69(1):42-50. Epub 2016 Nov 14.

23.

Serum Bicarbonate and Structural and Functional Cardiac Abnormalities in Chronic Kidney Disease - A Report from the Chronic Renal Insufficiency Cohort Study.

Dobre M, Roy J, Tao K, Anderson AH, Bansal N, Chen J, Deo R, Drawz P, Feldman HI, Hamm LL, Hostetter T, Kusek JW, Lora C, Ojo AO, Shrama K, Rahman M; CRIC Study Investigators.

Am J Nephrol. 2016;43(6):411-20. doi: 10.1159/000446860. Epub 2016 May 28.

24.

APOL1-G0 or APOL1-G2 Transgenic Models Develop Preeclampsia but Not Kidney Disease.

Bruggeman LA, Wu Z, Luo L, Madhavan SM, Konieczkowski M, Drawz PE, Thomas DB, Barisoni L, Sedor JR, O'Toole JF.

J Am Soc Nephrol. 2016 Dec;27(12):3600-3610. Epub 2016 Mar 29.

25.

Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.

Drawz PE, Alper AB, Anderson AH, Brecklin CS, Charleston J, Chen J, Deo R, Fischer MJ, He J, Hsu CY, Huan Y, Keane MG, Kusek JW, Makos GK, Miller ER 3rd, Soliman EZ, Steigerwalt SP, Taliercio JJ, Townsend RR, Weir MR, Wright JT Jr, Xie D, Rahman M; Chronic Renal Insufficiency Cohort Study Investigators.

Clin J Am Soc Nephrol. 2016 Apr 7;11(4):642-52. doi: 10.2215/CJN.08530815. Epub 2016 Feb 18.

26.

The Brain in Kidney Disease (BRINK) Cohort Study: Design and Baseline Cognitive Function.

Murray AM, Bell EJ, Tupper DE, Davey CS, Pederson SL, Amiot EM, Miley KM, McPherson L, Heubner BM, Gilbertson DT, Foley RN, Drawz PE, Slinin Y, Rossom RC, Lakshminarayan K, Vemuri P, Jack CR, Knopman DS.

Am J Kidney Dis. 2016 Apr;67(4):593-600. doi: 10.1053/j.ajkd.2015.11.008. Epub 2015 Dec 29.

27.

Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.

Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, Brecklin CS, Drawz P, Flack JM, Miller ER 3rd, Steigerwalt SP, Townsend RR, Weir MR, Wright JT Jr, Rahman M; CRIC Study Investigators.

Hypertension. 2016 Feb;67(2):387-96. doi: 10.1161/HYPERTENSIONAHA.115.06487. Epub 2015 Dec 28.

28.

Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.

Drawz P, Ayyappan S, Nouraie M, Saraf S, Gordeuk V, Hostetter T, Gladwin MT, Little J.

Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.

29.

Development and Implementation of Team-Based Panel Management Tools: Filling the Gap between Patient and Population Information Systems.

Watts B, Lawrence RH, Drawz P, Carter C, Shumaker AH, Kern EF.

Popul Health Manag. 2016 Aug;19(4):232-9. doi: 10.1089/pop.2015.0093. Epub 2015 Oct 6.

PMID:
26440062
30.

Dual Renin-Angiotensin-Aldosterone System Inhibition for the Treatment of Diabetic Kidney Disease: Adverse Effects and Unfulfilled Promise.

El-Haddad B, Reule S, Drawz PE.

Curr Diab Rep. 2015 Oct;15(10):70. doi: 10.1007/s11892-015-0640-3. Review.

PMID:
26275442
31.

Influence of Nephrologist Care on Management and Outcomes in Adults with Chronic Kidney Disease.

Ricardo AC, Roy JA, Tao K, Alper A, Chen J, Drawz PE, Fink JC, Hsu CY, Kusek JW, Ojo A, Schreiber M, Fischer MJ; CRIC Study Investigators.

J Gen Intern Med. 2016 Jan;31(1):22-9. doi: 10.1007/s11606-015-3452-x. Epub 2015 Jul 3.

32.

CKD as a Model for Improving Chronic Disease Care through Electronic Health Records.

Drawz PE, Archdeacon P, McDonald CJ, Powe NR, Smith KA, Norton J, Williams DE, Patel UD, Narva A.

Clin J Am Soc Nephrol. 2015 Aug 7;10(8):1488-99. doi: 10.2215/CJN.00940115. Epub 2015 Jun 25.

33.

Chronic kidney disease.

Drawz P, Rahman M.

Ann Intern Med. 2015 Jun 2;162(11):ITC1-16. doi: 10.7326/AITC201506020. Review.

PMID:
26030647
34.

A pharmacist based intervention to improve the care of patients with CKD: a pragmatic, randomized, controlled trial.

Cooney D, Moon H, Liu Y, Miller RT, Perzynski A, Watts B, Drawz PE.

BMC Nephrol. 2015 Apr 16;16:56. doi: 10.1186/s12882-015-0052-2.

35.

Physiological approach to assessment of acid-base disturbances.

Sheta MA, Hostetter T, Drawz P.

N Engl J Med. 2015 Jan 8;372(2):194-5. doi: 10.1056/NEJMc1413880. No abstract available.

PMID:
25564917
36.

Slowing progression of chronic kidney disease.

Drawz PE, Rosenberg ME.

Kidney Int Suppl (2011). 2013 Dec;3(4):372-376.

37.

Risk factors for acute gastrointestinal bleeding following myocardial infarction in veteran patients who are prescribed clopidogrel.

Cuschieri JR, Drawz P, Falck-Ytter Y, Wong RC.

J Dig Dis. 2014 Apr;15(4):195-201. doi: 10.1111/1751-2980.12123.

PMID:
24373542
38.

Heart rate variability is a predictor of mortality in chronic kidney disease: a report from the CRIC Study.

Drawz PE, Babineau DC, Brecklin C, He J, Kallem RR, Soliman EZ, Xie D, Appleby D, Anderson AH, Rahman M; CRIC Study Investigators.

Am J Nephrol. 2013;38(6):517-28. doi: 10.1159/000357200. Epub 2013 Dec 14.

39.

A simple tool to predict end-stage renal disease within 1 year in elderly adults with advanced chronic kidney disease.

Drawz PE, Goswami P, Azem R, Babineau DC, Rahman M.

J Am Geriatr Soc. 2013 May;61(5):762-8. doi: 10.1111/jgs.12223. Epub 2013 Apr 25.

40.

Association of serum bicarbonate with risk of renal and cardiovascular outcomes in CKD: a report from the Chronic Renal Insufficiency Cohort (CRIC) study.

Dobre M, Yang W, Chen J, Drawz P, Hamm LL, Horwitz E, Hostetter T, Jaar B, Lora CM, Nessel L, Ojo A, Scialla J, Steigerwalt S, Teal V, Wolf M, Rahman M; CRIC Investigators.

Am J Kidney Dis. 2013 Oct;62(4):670-8. doi: 10.1053/j.ajkd.2013.01.017. Epub 2013 Mar 13.

41.

Outbreak of fluoroquinolone-resistant Escherichia coli infections after transrectal ultrasound-guided biopsy of the prostate.

Dumford D 3rd, Suwantarat N, Bhasker V, Kundrapu S, Zabarsky TF, Drawz P, Zhu H, Donskey CJ.

Infect Control Hosp Epidemiol. 2013 Mar;34(3):269-73. doi: 10.1086/669512. Epub 2013 Jan 16.

PMID:
23388361
42.

Cardiovascular risk assessment: addition of CKD and race to the Framingham equation.

Drawz PE, Baraniuk S, Davis BR, Brown CD, Colon PJ Sr, Cujyet AB, Dart RA, Graumlich JF, Henriquez MA, Moloo J, Sakalayen MG, Simmons DL, Stanford C, Sweeney ME, Wong ND, Rahman M.

Am Heart J. 2012 Dec;164(6):925-31.e2. doi: 10.1016/j.ahj.2012.09.003. Epub 2012 Oct 29.

43.

Effective antimicrobial stewardship in a long-term care facility through an infectious disease consultation service: keeping a LID on antibiotic use.

Jump RL, Olds DM, Seifi N, Kypriotakis G, Jury LA, Peron EP, Hirsch AA, Drawz PE, Watts B, Bonomo RA, Donskey CJ.

Infect Control Hosp Epidemiol. 2012 Dec;33(12):1185-92. doi: 10.1086/668429. Epub 2012 Oct 25.

44.

Acyclovir induced hypokalemia.

Drawz PE, Perez F, Bonomo RA.

J Clin Virol. 2013 Feb;56(2):177-8. doi: 10.1016/j.jcv.2012.10.002. Epub 2012 Nov 2. No abstract available.

45.

Heart rate and blood pressure: any possible implications for management of hypertension?

Reule S, Drawz PE.

Curr Hypertens Rep. 2012 Dec;14(6):478-84. doi: 10.1007/s11906-012-0306-3. Review.

46.

Impact of a chronic kidney disease registry and provider education on guideline adherence--a cluster randomized controlled trial.

Drawz PE, Miller RT, Singh S, Watts B, Kern E.

BMC Med Inform Decis Mak. 2012 Jul 5;12:62. doi: 10.1186/1472-6947-12-62.

47.

Blood pressure measurement: clinic, home, ambulatory, and beyond.

Drawz PE, Abdalla M, Rahman M.

Am J Kidney Dis. 2012 Sep;60(3):449-62. doi: 10.1053/j.ajkd.2012.01.026. Epub 2012 Apr 21. Review.

48.

Metabolic complications in elderly adults with chronic kidney disease.

Drawz PE, Babineau DC, Rahman M.

J Am Geriatr Soc. 2012 Feb;60(2):310-5. doi: 10.1111/j.1532-5415.2011.03818.x. Epub 2012 Jan 27.

49.

Family history and kidney disease.

Drawz PE, Sedor JR, Hostetter TH.

Am J Kidney Dis. 2012 Jan;59(1):9-10. doi: 10.1053/j.ajkd.2011.11.012. No abstract available.

PMID:
22177445
50.

The genetics of common kidney disease: a pathway toward clinical relevance.

Drawz PE, Sedor JR.

Nat Rev Nephrol. 2011 Jun 28;7(8):458-68. doi: 10.1038/nrneph.2011.85. Review.

PMID:
21712849

Supplemental Content

Support Center